Dan Loeb's Third Point Cuts Stake in Nabi Biopharma (NABI) to 12.1%

March 30, 2010 5:41 PM EDT Send to a Friend
In a 13D filing after the close, Daniel ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login